NBIIX
Price
$15.16
Change
+$0.21 (+1.40%)
Updated
Feb 3 closing price
Net Assets
1.14B
RERFX
Price
$63.92
Change
-$1.68 (-2.56%)
Updated
Feb 3 closing price
Net Assets
134.63B
Interact to see
Advertisement

NBIIX vs RERFX

Header iconNBIIX vs RERFX Comparison
Open Charts NBIIX vs RERFXBanner chart's image
Neuberger International Eq I
Price$15.16
Change+$0.21 (+1.40%)
VolumeN/A
Net Assets1.14B
American Funds EUPAC R5
Price$63.92
Change-$1.68 (-2.56%)
VolumeN/A
Net Assets134.63B
NBIIX vs RERFX Comparison Chart in %
View a ticker or compare two or three
VS
NBIIX vs. RERFX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBIIX is a Buy and RERFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERFX has more cash in the bank: 135B vs. NBIIX (1.14B). RERFX pays higher dividends than NBIIX: RERFX (2.80) vs NBIIX (1.17). NBIIX was incepted earlier than RERFX: NBIIX (21 years) vs RERFX (24 years). NBIIX (1.03) is less costly to investors than RERFX (0.52). NBIIX is a more actively managed with annual turnover of: 61.00 vs. RERFX (35.00). RERFX has a lower initial minimum investment than NBIIX: RERFX (250) vs NBIIX (1000000). RERFX annual gain was more profitable for investors over the last year : 18.72 vs. NBIIX (17.72). NBIIX return over 5 years is better than : 8.66 vs. RERFX (-2.76).
NBIIXRERFXNBIIX / RERFX
Total Expense Ratio0.850.52163%
Annual Report Gross Expense Ratio1.030.52198%
Fund Existence21 years24 years-
Gain YTD6.4615.670114%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.14B135B1%
Annual Yield % from dividends1.172.8042%
Returns for 1 year17.7218.7295%
Returns for 3 years32.6026.85121%
Returns for 5 years8.66-2.76-313%
Returns for 10 years68.7969.4199%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOVE13.300.12
+0.91%
Lovesac Company (The)
AVBP22.64-0.04
-0.15%
ArriVent BioPharma
LNTH66.00-0.50
-0.75%
Lantheus Holdings
CUK31.76-0.39
-1.21%
Carnival PLC
LIQT1.65-0.07
-4.07%
LiqTech International